Citigroup’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-30,071
Closed -$11K 5126
2016
Q3
$11K Buy
30,071
+1,385
+5% +$507 ﹤0.01% 4431
2016
Q2
$14K Sell
28,686
-131,565
-82% -$64.2K ﹤0.01% 4390
2016
Q1
$218K Buy
160,251
+100,143
+167% +$136K ﹤0.01% 3404
2015
Q4
$89K Buy
60,108
+49,882
+488% +$73.9K ﹤0.01% 3670
2015
Q3
$16K Sell
10,226
-2,075
-17% -$3.25K ﹤0.01% 4184
2015
Q2
$21K Sell
12,301
-6,097
-33% -$10.4K ﹤0.01% 4249
2015
Q1
$26K Sell
18,398
-12,137
-40% -$17.2K ﹤0.01% 4271
2014
Q4
$46K Buy
30,535
+16,102
+112% +$24.3K ﹤0.01% 4145
2014
Q3
$29K Sell
14,433
-10,672
-43% -$21.4K ﹤0.01% 4048
2014
Q2
$77K Sell
25,105
-3,411
-12% -$10.5K ﹤0.01% 3268
2014
Q1
$72K Sell
28,516
-27,539
-49% -$69.5K ﹤0.01% 3740
2013
Q4
$278K Buy
56,055
+48,744
+667% +$242K ﹤0.01% 2873
2013
Q3
$16K Buy
7,311
+7,111
+3,556% +$15.6K ﹤0.01% 4399
2013
Q2
$0 Buy
+200
New ﹤0.01% 5259